C2C Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-39,369
Closed -$2.73M 129
2023
Q3
$2.73M Buy
39,369
+3,600
+10% +$255K 0.39% 26
2023
Q2
$2.55M Buy
35,769
+11,373
+47% +$809K 0.34% 31
2023
Q1
$1.83M Buy
24,396
+12,755
+110% +$1.07M 0.29% 42
2022
Q4
$1.02M Sell
11,641
-241
-2% -$23.3K 0.18% 60
2022
Q3
$1.19M Buy
11,882
+172
+1% +$17K 0.23% 53
2022
Q2
$1.13M Sell
11,710
-152
-1% -$14.8K 0.21% 59
2022
Q1
$1.25M Sell
11,862
-192
-2% -$20.2K 0.21% 61
2021
Q4
$1.24M Buy
+12,054
New +$1.11M 0.18% 73

Other funds holding CVS

C2C Wealth Management's CVS Position: Q4 2023 in Review

C2C Wealth Management sold out of CVS Health (CVS) in Q4 2023, closing a stake of 39,369 shares — an estimated $2.73M sold.

C2C Wealth Management first reported a position in CVS in Q4 2021 and held it in 8 quarters. The position peaked at $2.73M in Q3 2023. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • C2C Wealth Management reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
  • C2C Wealth Management sold 39,369 CVS Health shares in Q4 2023, an estimated $2.73M.
  • C2C Wealth Management first reported a position in CVS Health in Q4 2021 and held it in 8 quarters.
  • C2C Wealth Management's CVS Health position peaked at $2.73M in Q3 2023.
  • 2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on C2C Wealth Management's 13F filing for Q4 2023, filed 13 Feb 2024.